Work

A randomized, double-blind phase III study of ibrutinib versus placebo in combination with corticosteroids in patients with new onset chronic graft versus host disease.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps7072

Authors: David Bernard Miklos, Madan H. Jagasia, Hildegard Greinix, Bor-Sheng Ko, David A. Jacobsohn, Ahmad Mokatrin, Jason Dubovsky, Biljana Horn, Bernhard Hauns, Lori Appel Styles, Mary Flowers

Institutions: Stanford Medicine, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Medical University of Graz, National Taiwan University Hospital, Children's National, Pharmacyclics (United States), Seattle Cancer Care Alliance, Fred Hutch Cancer Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890082104

Cites:

Cited by: 4

Related to: 10